StockNews.com Initiates Coverage on CASI Pharmaceuticals (NASDAQ:CASI) : vimarsana.com

StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report sent to investors on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright increased their price target on CASI Pharmaceuticals from $10.00 to $12.00 and gave the stock a buy rating in a […]

Related Keywords

United States , , Virtu Financial , Pharmaceuticals Trading Down , Susquehanna International Group , Renaissance Technologies , Pharmaceuticals Company Profile , Pharmaceuticals Daily , Pharmaceuticals Inc , Citigroup Inc , Free Report , Trading Down , International Group , Get Free Report , Casi Pharmaceuticals , Nasdaq Casi , Casi , Medical , Initiated Coverage , Stocknews Com ,